BioAtla, Inc.
BCAB
$0.356
-$0.0002-0.06%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -22.02% | -3.02% | -40.60% | 49.76% | 9.31% |
Total Depreciation and Amortization | -37.16% | -19.74% | 0.00% | -0.44% | -4.58% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 812.34% | -120.91% | -48.77% | -12.10% | 8.52% |
Change in Net Operating Assets | 410.64% | 72.25% | -207.22% | 458.39% | 91.65% |
Cash from Operations | 13.31% | 2.95% | -227.03% | 73.26% | 37.74% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
Repurchase of Common Stock | 82.76% | -- | 100.00% | 26.32% | -46.15% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 78.69% | -- | -- | -- | -- |
Cash from Financing | 90.89% | -104.24% | 66,621.43% | -106.22% | 1,830.77% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 15.15% | -123.33% | -45.16% | 72.87% | 38.50% |